Last reviewed · How we verify

NCT04787861

Motorized Movement Therapy & Pulmonary Functions in Down Syndrome

Completed NA Last updated 9 March 2021
What this trial tests

NA trial testing motorized movement therapy in Pulmonary Functions in 40 participants. Completed in 4 May 2020.

Timeline
17 December 2018
Primary endpoint
7 March 2020
4 May 2020

Quick facts

Lead sponsorTaibah University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment40
Start date17 December 2018
Primary completion7 March 2020
Estimated completion4 May 2020
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Taibah University

Who can join

Adults 9 to 13, any sex, with Pulmonary Functions or Down Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effects of the addition of motorized movement therapy versus conventional chest physiotherapy alone on pulmonary functions, exercise capacity, and endurance in children with Down Syndrome

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Functions

Currently open trials in the same condition.

Other Taibah University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04787861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing